Rheumocam

Authorised

This medicine is authorised for use in the European Union

meloxicam

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Rheumocam : EPAR - Medicine overview

Product information

Rheumocam : EPAR - Product Information

Rheumocam : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Rheumocam
• Active substance:
  meloxicam
• International non-proprietary name (INN) or common name:
  meloxicam

Pharmacotherapeutic group

• Oxicams
• Anti-inflammatory and anti-rheumatic products, non-steroids

Authorisation details

• EMA product number:
  EMEA/V/C/000121
• Generic:

  This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Assessment history

Changes since initial authorisation of medicine

Rheumocam : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Rheumocam (VRA-I-0038)

AdoptedReference Number: EMA/CVMP/81597/2025

CVMP post-authorisation summary of positive opinion for Rheumocam (X-0022)

AdoptedReference Number: EMA/CVMP/529543/2018

Rheumocam-V-C-121-X-0015 : EPAR - Assessment Report - Extension

Adopted

CVMP post-authorisation summary of positive opinion for Rheumocam

AdoptedReference Number: EMA/CVMP/106521/2015

Rheumocam-V-C-121-X-0010 : EPAR - Assessment Report - Extension

Rheumocam-V-C-121-X-0008 : EPAR - Assessment Report - Extension

Adopted

CVMP post-authorisation summary of positive opinion for Rheumocam

AdoptedReference Number: EMA/CVMP/765011/2011

Rheumocam-V-C-121-X-0007 : EPAR - Scientific Discussion - Extension

Adopted

CVMP post-authorisation summary of positive opinion for Rheumocam

AdoptedReference Number: EMA/CVMP/9999/2011

Rheumocam-V-C-121-X-0006 : EPAR - Scientific Discussion - Extension

Adopted

CVMP post-authorisation summary of positive opinion for Rheumocam

AdoptedReference Number: EMA/CVMP/147814/2010

Initial marketing authorisation documents

Rheumocam : EPAR - Scientific Discussion

CVMP summary of opinion for Rheumocam

AdoptedReference Number: EMEA/CVMP/398949/2009

Rheumocam : EPAR - Procedural steps taken before authorisation